Although vaccines were solely responsible for the globaleradication of smallpox (1980) and polio (2015), several vaccine-preventablediseases, such as measles and mumps, are still a threat; COVID-19 has been recentlyadded to the list
Roots Analysis is pleased toannounce the publication of its recent study, titled, “Global PreventiveVaccines Market, 2020-2030”.
Thereport features an extensive study of the current market landscape and futureopportunities associated with the preventive vaccine domain. The study alsofeatures a detailed analysis of the key drivers and trends related to thisevolving segment of the pharmaceutical industry. Amongst other elements, thereport includes:
§ Adetailed assessment of the current market landscape, featuring clinical-stagepreventive vaccines.
§ A competitivenessanalysis of preventive vaccine developers, featuring insightful pictorialsummaries and representations.
§ Elaborateprofiles of the key preventive vaccine developers (shortlisted based on aproprietary criterion) across North America, Europe and Asia Pacific.
§ An in-depthanalysis of the completed, ongoing and planned trials of various preventivevaccines.
§ Anoverview of the ongoing vaccine development initiatives for complex conditions,such as COVID-19, Ebola virus disease, HIV/AIDS, malaria and zika virus infection.
§ Ananalysis of the investments made in this domain, during the period between 2015and 2020 (till March).
§ Acase study on contract manufacturing landscape for vaccines, featuring the CMOsengaged in this domain.
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Routeof Administration
§ Intramuscular
§ Subcutaneous
§ Oral
§ Intravenous
§ Others
To Request for sample report - https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
§ Typeof Vaccine
§ Pneumococcal Conjugate Vaccine
§ Human Papilloma Virus Vaccine
§ Rotavirus Vaccine
§ Influenza Vaccine
§ MMR Vaccine
§ Tetanus and Diphtheria Booster Vaccine
§ Varicella Vaccine
§ DTaP-Hib-IPV Vaccine
§ DTaP-HepB-Hib-IPV Vaccine
§ Others
§ Typeof Vaccine API
§ Live, Attenuated Vaccine
§ Inactivated Vaccine
§ Conjugate Vaccine
§ Subunit Vaccine
§ Toxoid Vaccine
§ Others
§ TargetPatient Population
§ PediatricPatients
§ Adults
§ KeyPlayers
§ GlaxoSmithKline
§ Merck
§ SanofiPasteur
§ Pfizer
§ EmergentBioSolutions
§ CSL
§ Others
§ KeyGeographical Regions
§ NorthAmerica
§ Europe
§ AsiaPacific
§ Restof the World
Keycompanies covered in the report
§ Bio Farma
§ Emergent BioSolutions
§ GC Pharma
§ GlaxoSmithKline
§ Janssen
§ Merck
§ Novavax
§ Pfizer
§ Sanofi Pasteur
§ Valneva
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
Other Recent Offerings
§ Novelcoronavirus (COVID-19): Preventive Vaccines, Therapeuticsand Diagnostics in Development
§ Novel Vaccine DeliveryDevices Market, 2019-2030 [COVID-19 SERIES]
§ Vaccine ContractManufacturing Market (2nd Edition), 2019-2030 [COVID-19 SERIES]
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in thebio-pharmaceutical industry. The in-depth research, analysis and insights aredriven by an experienced leadership team which has gained many years ofsignificant experience in this sector. If you’d like help with your growingbusiness needs, get in touch at info@rootsanalysis.com
Contact Information
Gaurav Chaudhary
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter- https://twitter.com/RootsAnalysis
